Author: Meital Gotfrid

Senior Director, Academia. Technological Infrastructure Division

Noa Matarasso, PhD serve as Senior Director of Academia in the Technological and Infrastructure division at the Israel Innovation Authority and manage the Academic programs. Previously to her work in the Israel innovation Authority, Noa held a  position as Discovery Manager and Trait Biotech Manager at Evogene. Dr. Matarasso holds a PhD in Molecular Biology at the Plant Genetics faculty from the Tel Aviv University and had a PostDoc in Genetics of Prostate Cancer from The Sourasky Medical Center at Tel Aviv University

10:00-10:20  |   Opening Remarks

10:20-11:30  |  Unmet Needs and Technological Solutions

11:30-11:45   |   Open Discussion 

10:00-10:20  |   Opening Remarks

10:20-11:40  |  Unmet Needs and Technological Solutions

11:40 -12:00 |   Open Discussion 

B.Sc. Technion, 2005 (summa  cum laude). From 2005 till 2010, special track PhD, Technion. From 2010 to 2012, postdoctoral researcher CalTech (GALCIT). Currently Associate Professor at the Faculty of Mechanical Engineering, Technion – Israel Institute of Technology.

Professor Shulamit Levenberg serves as the director of the Technion Center for 3D Bioprinting and The Rina & Avner Schneur Center for Diabetes Research. She earned her PhD at the Weizmann Institute of Science, where she focused on cell adhesion dynamics and signaling, and pursued her post-doctoral research in tissue engineering at MIT, in the lab of Professor Robert Langer. In 2004, she joined the Technion Faculty of Biomedical Engineering where she conducts interdisciplinary research on stem cells and tissue engineering. She spent a sabbatical year (2011-2012) as a visiting professor at the Wyss Institute for Biology Inspired Engineering at Harvard University and a summer sabbatical (2017) at the University of Western Australia as a winner of the Raine Visiting Professor Award.  Prof Levenberg received the Krill Prize for excellence in scientific research, awarded by the Wolf Foundation, and was named by Scientific American as a “Research Leader” in tissue engineering, for her seminal work on vascularization of engineered tissues, improving survival and perfusion of engineered grafts. She also received the France-Israel Foundation Prize, the Italian Excellence for Israel Prize, the Teva Research Prize and the Juludan Prize. In 2018, she received the Rappaport Prize for Biomedical Sciences and in 2019 received the Bruno prize.  Levenberg has authored over 100 publications, and presented her work in over 100 international conferences as an invited or keynote speaker. She is founder and CSO of three start-up companies in the areas of cultured meat, nanoliter arrays for rapid antimicrobial susceptibility testing and spinal cord regeneration.  She is a former member of the Israel National Counsel for Bioethics and is actively involved in training young scientists. During the last 4 years Prof. Levenberg was the elected Dean of the Technion Faculty of Biomedical Engineering.

Avi Schroeder is an Associate Professor of Chemical Engineering at the Technion – Israel Institute of Technology where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (https://www.schroederlab.com/ ).

Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD jointly at the Hebrew and Ben Gurion Universities.

Avi is the recipient of more than 30 national and international awards, including named a KAVLI Fellow, the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Awards. Avi is the author of more than 50 research papers inventor of 19 patents and co-founder of several startup companies based on these discoveries.

Schroeder is a member of Israel Young National Academy of Sciences, and the President of the Israel Institute of Chemical Engineers.